{
    "medicine_id": "d596cfe2aca480957f16d60c78a401e6a18e7a5b",
    "platform_id": "DB13891",
    "metadata": {
        "name": "CroFab Injection powder lyophilized for solution",
        "composition": "Crotalus scutulatus antivenin",
        "clinical_particulars": {
            "therapeutic_indications": "CROFAB is indicated for the management of adult and pediatric patients with North American crotalid envenomation The term crotalid is used to describe the Crotalinae subfamily formerly known as Crotalidae of venomous snakes which includes rattlesnakes copperheads and cottonmouths water moccasins FDA label",
            "contraindications": {
                "disease": "Ed50 for the Crotolus scutulatus snake evenomation is 8 mg antivenin mg venom FDA label Most common adverse reactions incidence 5 of subjects were urticaria rash nausea pruritus and back pain Hypersensitivity reactions may also occur FDA label Hypersensitivity reactions can occur to substances derived from sheep plasma anaphylaxis and anaphylactoid reactions are possible especially in patients with known allergies to sheep protein Immediate treatment including epinephrine 1 mg mL for anaphylaxis and or hypersensitivity reactions must be available prior to administration In cases of acute hypersensitivity reactions including anaphylaxis and anaphylactoid reactions discontinue infusion and institute appropriate emergency treatment Sensitization may occur with repeated doses of antivenin L2859 Drugs such as crotalidae antivenin which are processed with papain may lead to hypersensitivity reactions in patients allergic to papaya other papaya extracts papain chymopapain or the pineapple enzyme _bromelain_ There may also be cross allergenicity with dust mite and latex allergens L2859 Late serum reactions rash pruritus urticaria or serum sickness consisting of severe rash and pruritus reported in 12 5 42 of patients in initial clinical trials have been observed and delayed hypersensitivity or serum sickness reported in 5 11 of patients in other studies L2859",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Acts as an antivenin relieving symptoms of envenomation from Crotalinae family of snakes and preventing lethal consequences of snake evenomation FDA label The Crotalidae family produces venoms which are generally necrolytic and hemolyzing to tissues Hemorrhagins in crotalid venom is toxic to the blood vessels and therefore cause hemorrhage and edema at the wound site in addition to systemic hemorrhage and shock Significant anemia is observed due to hemolysis and extravasation of blood due to damaged vessels Disseminated intravascular coagulation DIC has been observed in some cases The most frequent initial clinical pathological changes include echinocytosis thrombocytopenia leukocytosis and prolonged activated clotting time In general edema and erythema along with fang marks _Crotalidae _family may be seen at the site of bite although it is tough to identify due to thick hair coat in animals L2889 Patients sustaining rattlesnake envenomation often develop thrombocytopenia the etiology of which is not clear It has been shown thatCrotaline Fab antivenom improved platelet aggregation in an in vitro model of platelet dysfunction induced by venom from C scutulatus A33153",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}